Last updated on August 2019

Study in Subjects With Small Primary Choroidal Melanoma

Brief description of study

The primary objective is to assess the safety, immunogenicity and efficacy of one of three dose levels and repeat dose regimens of Light-activated AU-011 and one or two laser applications for the treatment of subjects with primary choroidal melanoma.

Detailed Study Description

This is a phase 1B/2 open-label, ascending single and repeat dose clinical trial designed to evaluate the safety and efficacy of Light-activated AU-011 for the treatment of subjects with small primary choroidal melanoma.

Throughout the study, subjects will be monitored through medical and ophthalmic assessments. Subjects will be followed for a total of 2 years.

Clinical Study Identifier: NCT03052127

Find a site near you

Start Over

Retina Associates of Utah

Salt Lake City, UT United States
  Connect »